The portal venous system refers to the veins that drain blood from the intestines, stomach, pancreas, esophagus and spleen into the liver prior to entering the main or systemic circulation. All ...

The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute ...

May 13, 2010 — Eltrombopag (Promacta; GlaxoSmithKline) has been linked to an increased risk for portal venous thrombosis in patients with thrombocytopenia due to chronic liver disease, and the company ...

GlaxoSmithKline and the FDA notified healthcare professionals of a new safety finding in patients with thrombocytopenia due to chronic liver disease treated with Promacta (eltrombopag tablets). The ...

Doppler ultrasonography is the first imaging technique to be used for portal vein thrombosis (PVT) diagnosis; it is well-tolerated, accurate and a negative examination performed by a trained operator ...

A recent study aimed to evaluate the effectiveness and safety of systemic thrombolysis for acute portal vein thrombosis in patients with liver cirrhosis. Ten compensated cirrhotic patients with acute ...

SHORTLY after Abeatici and Campi, 1 in 1951, introduced direct percutaneous splenic puncture as a method of performing splenoportal venography in dogs this became the standard roentgenographic method ...

Common complications of nephrotic syndrome include infections, development of a hypercoagulable state, and venous thrombosis. [1] Venous thrombosis occurs most often in the renal veins and in the ...

Portal Hypertension Symptoms and Their ComplicationsPortal hypertension is a condition in which increased pressure within the portal vein—an important vessel that carries blood from the stomach and ...

Portal hypertension is one of the main consequences of cirrhosis. It results from a combination of increased intrahepatic vascular resistance and increased blood flow through the portal venous system.